glp 1 lasker Scientists who discovered the Glucagon Yusa peptide (GLP-1) were selected as winners of the P Super GLP-1 Support + Akkermansia

Gallup polled U.S

GLP-1s account for 23% of first line diabetes therapy in 2025 up from 3% in 2021 Since 2019, the American Diabetes Association (ADA) has revised its Standards of Care each year to expand the role of GLP-1 receptor agonists and SGLT2 inhibitors as first-line treatments for T2D2

A recent meta-analysis found that GLP-1 medications like Ozempic and Wegovy may help lower blood pressure

Complete guide covering sodium, potassium, magnesium protocols for semaglutide and tirzepatide users.

Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD

Ideal for morning routines, workouts, or busy days, this energizing formula helps sustain physical activity throughout the day